Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston
News Jul 24, 2015
Paratek Pharmaceuticals, Inc. has opened its new corporate headquarters in Boston at 75 Park Plaza.
"This move comes at an important time for Paratek, as we have recently initiated a global Phase 3 program for our lead antibiotic compound, omadacycline. With two important products in Phase 3 clinical studies, we are now preparing for the next phase of our growth as a biopharmaceutical company," said Michael Bigham, Chairman and Chief Executive Officer, Paratek. "The Company takes pride in its origins as a Boston-based biopharmaceutical company, and we look forward to our continued growth here in Boston."
The address of the new headquarters is 75 Park Plaza, 4th floor, Boston, MA 02116. Paratek was previously located at 75 Kneeland Street in Boston. In June Paratek opened a second office location in the Philadelphia area.
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019
2nd International Conference on Biological & Pharmaceutical Sciences
Jul 12 - Jul 13, 2019
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019